Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.46
|
2.99
|
2.72
|
2.71
|
2.72
|
2.71
|
|
|
711.31
|
10.00
|
2.56
|
3.11
|
3.05
|
2.66
|
3.05
|
2.66
|
|
|
17 952.98
|
28.00
|
2.58
|
3.29
|
2.70
|
2.65
|
2.70
|
2.65
|
|
|
216.00
|
3.00
|
2.46
|
2.78
|
2.73
|
2.677
|
2.73
|
2.677
|
|
|
18.80
|
5.00
|
2.30
|
5.55
|
2.53
|
2.53
|
2.5987
|
2.5987
|
|
|
427.83
|
8.00
|
2.52
|
3.29
|
2.65
|
2.5615
|
2.65
|
2.5615
|
|
|
18.55
|
3.00
|
2.41
|
2.95
|
2.76
|
2.55
|
2.76
|
2.55
|
|
|
2 286.49
|
18.00
|
2.67
|
2.77
|
2.99
|
2.63
|
2.99
|
2.645
|
|
|
13 572.28
|
51.00
|
2.80
|
3.00
|
2.60
|
2.60
|
2.93
|
2.93
|
|
|
1 917.65
|
9.00
|
2.52
|
2.75
|
2.83
|
2.59
|
2.83
|
2.59
|
|
|
12 167.47
|
33.00
|
XORTX Therapeutics Inc (XORTX) is a drug development company primarily focused on orphan disease indications which have a uric acid imbalance as well as metabolic syndrome, diabetes and diabetic nephropathy